Practices
Education
- J.D., New York University School of Law, 1977
- A.B., University of Chicago, Honors, 1970
Bar Admissions
- New York (1978)
News
- Partner Stephen Goodman To Give Master Class On Pharma/Biotech Collaborative Agreements
- Partner Stephen Goodman Co-Edits ABA Publication "The SciTech Lawyer"
- Partner Stephen M. Goodman Quoted In Mergers & Acquisitions Article About Spinoffs
- Partner Stephen Goodman Quoted By Reuters On News Corp. Bid For Dow Jones
- Partner Stephen Goodman Authors Article on How to Avoid Violating Export Control Regulations
- Pryor Cashman Assists Biotechnology Investment Company in Formation and Investments
- Pryor Cashman Represents Nastech Pharmaceuticals in Drug Development Deal with Amylin Pharmaceuticals
- Pryor Cashman Team Negotiates Supply Agreement Between Nastech Pharmaceuticals and Procter & Gamble
- Pryor Cashman Hosts Seminar on Tissue Regeneration Without Use of Embryonic Stem Cells
- Partner Stephen Goodman Chairs Conference on Corporate Governance
- Pryor Cashman Represents Nastech Pharmaceutical in Business Expansion Transactions
- Pryor Cashman Completes Three Acquisitions for Leading Multinational Publisher
Publications
Events
- Partner Stephen Goodman To Give Master Class On Pharma/Biotech Collaborative Agreements
- Pryor Cashman Partner Stephen Goodman Involved In Planning Of Major Conference On Emerging Issues In Biotechnology Law
- Pryor Cashman Hosts Seminar on Tissue Regeneration Without Use of Embryonic Stem Cells
- Partner Stephen Goodman Chairs Conference on Corporate Governance
Print Email this page Vcard Attorneys
Stephen M. Goodman
Partnersgoodman@pryorcashman.com
410 Park Avenue
New York, NY 10022
New York, NY 10022
Direct Tel:
212-326-0146Direct Fax:
212-798-6340Stephen M. Goodman acts as outside general counsel to a variety of public and private companies, particularly those involved in the development, exploitation, purchase and sale of intellectual property and technology assets, such as publishing and media companies, computer software and Internet companies, and pharmaceutical and biotechnology companies. With extensive experience in mergers and acquisitions, as well as capital formation and corporate finance, his particular expertise encompasses domestic and cross-border grants or transfers of rights of these assets (including joint venture and product development arrangements as well as licensing, distribution and marketing agreements); and proprietary rights issues (including practical application of trade secret laws, development of employee policies on confidential information and related nondisclosure agreements).
Mr. Goodman has been responsible for negotiating and documenting the following representative transactions:
- A license for exclusive worldwide rights to patents and patent applications from an academic institution covering a naturally occurring peptide and its derivatives in the fields of obesity, appetite suppression, reducing food intake, inducing weight loss and inducing satiety
- A Feasibility Study, Option and License Agreement for the development of a client’s lead drug candidate for moderate-to-severe pain
- A private financing of $8.4 million to advance a client’s two lead drug programs, a new class of antibacterial agents targeting infectious disease called BAR (beta-lactam activity restoring) compounds and certain small molecules targeting inflammatory disease by disabling the TNF receptor
- An exclusive license to discover, develop, and commercialize RNAi therapeutics directed against TNF-alpha, a protein associated with inflammatory diseases including rheumatoid arthritis
- Acquisition of all patent rights for a group of compounds believed to have wound-healing and other regenerative properties, together with clinical trial data filed with regulatory agencies related to these compounds
- A “double-dummy” reverse merger to combine two development-stage biotechnology companies, creating a single company with multiple drug programs
- Form Master License and Maintenance Agreement for use with customers of client marketing sophisticated warehouse management software
- Agreements with major textbook publishers for conversion of print or electronic textbooks into interactive formats utilizing client’s proprietary software and coding
Mr. Goodman is a 1977 graduate of New York University School of Law, where he was Order of the Coif and Articles Editor of the Annual Survey of American Law.
Previous Positions
- Willkie Farr & Gallagher LLP, Associate (1977-80)
- McGraw Hill Publishing Co. (1972-74)
Publications
- Member, Editorial Board (2007-08) and Co-Editor, Winter 2008 issue, of The SciTech Lawyer (published by the American Bar Association Section of Science and Technology)
- Author, National Security and Scientific Research - Tips On How To Avoid Violating Export Control Regulations, Genetic Engineering News (February 2007)
- Author, Good Faith and the Directors' Duty to Seek Information, New York Law Journal, September 23, 2004
- Author, Raising Money on the Internet: What You Don't Know Could Hurt You, AlleyCat News, December 1999.
- Author, California Publicity Bill Pits Stars Against Studios, National L.J., Oct. 25, 1999, p.C-12
Teaching Positions
- Adjunct Professor of Copyright Law, Pace University School of Law (1996-97).
Professional Affiliations
- New York State Bar Association, Member, International Law Section, Committee on International Intellectual Property
- American Bar Association: Co-Chair of Corporate Governance Task Force of the Tort, Trial and Insurance Practice Section (2006); Member, Sections on Business Law; Science and Technology (Biotechnology Committee) and Intellectual Property
Other Activities
- Former President (2001-04) and Member of Executive Committee, Westchester (NY) Chapter, American Jewish Committee
- Member, Business Advisory Board, Institute for the Study of Aging/Alzheimer’s Drug Discovery Foundation
